The Street Is Finally Waking Up To Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Lexicon Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Lexicon Pharmaceuticals Inc is $715.20M. A total of 9.01 million shares were traded on the day, compared to an average of 3.11 shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, LXRX has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 290,000 and the disposition of 0 shares. Over the last 12 months, there were 47 BUYs and 9 SELLs from insiders. Insiders purchased 29,821,074 shares during that period but sold 178,167.

In the most recent transaction, COATS LONNEL bought 90,000 shares of LXRX for 1.05 per share on Nov 16. After the transaction, the Chief Executive Officer now owns 914,359 company shares. In a previous transaction on Nov 10, COATS LONNEL bought 10,000 shares at 1.01 per share. LXRX shares that Chief Executive Officer owns now total 824,359.

Among the insiders who bought shares, DEBBANE RAYMOND acquired of 148,820 shares on Oct 12 at a per-share price of $1.03. This resulted in the Director holding 1,340,847 shares of LXRX after the transaction. In another insider transaction, DEBBANE RAYMOND bought 342,874 shares at $1.08 per share on Oct 11. Company shares held by the Director now total 1,192,027.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for LXRX in the last 3 months, the mean price target is $5.15 with high estimates of $10.00 and low estimates of $1.45. In terms of 52-week highs and lows, LXRX has a high of $3.79 and a low of $0.92.

As of this writing, LXRX has an earnings estimate of $Recursion Pharmaceuticals, Inc. per share for the current quarter. EPS was calculated based on a consensus of Lexicon Pharmaceuticals, Inc. estimates, with a high estimate of $Xerox Holdings Corporation per share and a lower estimate of $Lantronix, Inc..

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. LXRX’s latest balance sheet shows that the firm has $86.74M in Cash & Short Term Investments as of fiscal 2021. There were $2.28M in debt and $22.12M in liabilities at the time. Its Book Value Per Share was $0.57, while its Total Shareholder’s Equity was $113.59M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXRX is Buy with a score of 4.00.

Most Popular

Related Posts